MEDIPURE SCANDINAVIA A/S: Financial statements 2015
CVR: 13275149
Source: annual report 2015, Danish Business Authority
01/07/2014 – 30/06/2015
MEDIPURE SCANDINAVIA A/S (CVR 13275149) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 94,519 and a net result of DKK 170,054 compared with DKK 591,634 the year before. That is a decrease of 83.8% compared with the year before. Equity in the 2015 report amounted to DKK 1,505,434. The solvency ratio was 72.6%.
- Gross Profit
- DKK 94,519
- Profit/Loss
- DKK 170,054
- Equity
- DKK 1,505,434
- Total Assets
- DKK 2,072,423
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 95K | 170K | 1.5M | - |
| 2014 | - | 582K | 592K | 1.9M | - |
| 2013 | - | 247K | 167K | 1.3M | - |
Official annual report
How creditworthy is MEDIPURE SCANDINAVIA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of October 31, 2015, Thomas Munch has joined the board of directors of MEDIPURE SCANDINAVIA A/S.
As of October 31, 2015, Inga Kathrine Mortensen has left the board of directors of MEDIPURE SCANDINAVIA A/S.
About MEDIPURE SCANDINAVIA A/S
MEDIPURE SCANDINAVIA A/S was a Danish company of the type Aktieselskab based in Risskov, founded in 1989. The company has been dissolved on 12 November 2025. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BAXA INTERNATIONAL ApS and ASX 14709 ApS. The company has 1 employee (2009). In 2024, the company reported a gross profit of DKK -24,760 and a net result of DKK -4,255 compared with DKK -5,675 the year before. Equity in the 2024 report amounted to DKK 789,098.
